CD-NP: An Innovative Designer Natriuretic Peptide Activator of Particulate Guanylyl Cyclase Receptors for Cardiorenal Disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-06-29

AUTHORS

Paul M. McKie, S. Jeson Sangaralingham, John C. Burnett

ABSTRACT

The natriuretic peptide (NP) family consists of structurally similar, although physiologically distinct, peptides that play an important role in cardiorenal homeostasis. CD-NP is a novel chimeric natriuretic peptide developed by the Mayo Clinic, in which the 15-amino acid COOH-terminus of dendroaspis NP is fused to C-type NP. CD-NP is a dual activator of NP receptors A and B, and therefore, possesses the strong antiproliferative and antifibrotic properties of C-type NP with the potent natriuretic, diuretic, and aldosterone-inhibiting properties of dendroaspis NP. CD-NP has favorable cardiorenal properties when compared to recombinant B-type NP (nesiritide), including preservation of glomerular filtration rate with minimal blood pressure-lowering effects. Thus, CD-NP has emerged as an appealing novel therapeutic strategy for heart failure. The endogenous NP system, the development rationale for CD-NP, as well as in vitro, animal, and human studies and future directions will be reviewed. More... »

PAGES

93-99

References to SciGraph publications

  • 2008-06. Insights into natriuretic peptides in heart failure: An update in CURRENT HEART FAILURE REPORTS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6

    DOI

    http://dx.doi.org/10.1007/s11897-010-0016-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1022530445

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20582736


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antihypertensive Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chimera", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Diuretics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Elapid Venoms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glomerular Filtration Rate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Heart Failure", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Intercellular Signaling Peptides and Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kidney", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Natriuretic Peptide, C-Type", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Peptides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Guanylate Cyclase-Coupled", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McKie", 
            "givenName": "Paul M.", 
            "id": "sg:person.01271304603.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271304603.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sangaralingham", 
            "givenName": "S. Jeson", 
            "id": "sg:person.01032132346.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032132346.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Burnett", 
            "givenName": "John C.", 
            "id": "sg:person.01001266776.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s11897-008-0016-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038509334", 
              "https://doi.org/10.1007/s11897-008-0016-y"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-06-29", 
        "datePublishedReg": "2010-06-29", 
        "description": "The natriuretic peptide (NP) family consists of structurally similar, although physiologically distinct, peptides that play an important role in cardiorenal homeostasis. CD-NP is a novel chimeric natriuretic peptide developed by the Mayo Clinic, in which the 15-amino acid COOH-terminus of dendroaspis NP is fused to C-type NP. CD-NP is a dual activator of NP receptors A and B, and therefore, possesses the strong antiproliferative and antifibrotic properties of C-type NP with the potent natriuretic, diuretic, and aldosterone-inhibiting properties of dendroaspis NP. CD-NP has favorable cardiorenal properties when compared to recombinant B-type NP (nesiritide), including preservation of glomerular filtration rate with minimal blood pressure-lowering effects. Thus, CD-NP has emerged as an appealing novel therapeutic strategy for heart failure. The endogenous NP system, the development rationale for CD-NP, as well as in vitro, animal, and human studies and future directions will be reviewed.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11897-010-0016-6", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1033049", 
            "issn": [
              "1546-9530", 
              "1546-9549"
            ], 
            "name": "Current Heart Failure Reports", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "7"
          }
        ], 
        "keywords": [
          "C-type NP", 
          "dendroaspis NP", 
          "blood pressure-lowering effect", 
          "aldosterone-inhibiting properties", 
          "pressure-lowering effect", 
          "particulate guanylyl cyclase receptors", 
          "glomerular filtration rate", 
          "novel therapeutic strategies", 
          "natriuretic peptide family", 
          "B-type NP", 
          "cardiorenal homeostasis", 
          "heart failure", 
          "natriuretic peptide", 
          "guanylyl cyclase receptors", 
          "cardiorenal disease", 
          "antifibrotic properties", 
          "filtration rate", 
          "Mayo Clinic", 
          "therapeutic strategies", 
          "human studies", 
          "peptide activator", 
          "cyclase receptors", 
          "peptide family", 
          "dual activator", 
          "clinic", 
          "activator", 
          "peptides", 
          "disease", 
          "important role", 
          "receptors", 
          "vitro", 
          "homeostasis", 
          "animals", 
          "future directions", 
          "failure", 
          "rationale", 
          "NP system", 
          "CdS NPs", 
          "study", 
          "role", 
          "rate", 
          "preservation", 
          "effect", 
          "acid", 
          "family", 
          "strategies", 
          "development rationale", 
          "terminus", 
          "system", 
          "NPs", 
          "properties", 
          "direction"
        ], 
        "name": "CD-NP: An Innovative Designer Natriuretic Peptide Activator of Particulate Guanylyl Cyclase Receptors for Cardiorenal Disease", 
        "pagination": "93-99", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1022530445"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11897-010-0016-6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20582736"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11897-010-0016-6", 
          "https://app.dimensions.ai/details/publication/pub.1022530445"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T16:58", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_521.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11897-010-0016-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    187 TRIPLES      21 PREDICATES      92 URIs      83 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11897-010-0016-6 schema:about N04b93ba5f4a940a2bc4d4935ebdc5531
    2 N1809a9ea0e8d4f0ca13647b3eba74e62
    3 N18b1c8ea037d432ebaff05248b1d177f
    4 N1e98abf6fae047589b93797e9f0182f6
    5 N3008976dedaf45ddab09ef3179b01856
    6 N4410560da8c549b39fe86b63ec2f7952
    7 N8d87309ff7c744dbad39c48c13d4ec41
    8 Na090158251454779a213eb88dbba093c
    9 Naa7db89f97a84a8b8d575300fee9d69a
    10 Nc20349fbd7e6495aa83862fc5028b8d6
    11 Nc274d3b2db0649709d1df522091dcbc4
    12 Nd11450996d274de58cf2b5162289737d
    13 Ne7550d0f08664ad9b9aa6333a12d03f5
    14 Nfeb54198a8b9411c8a6cd57ebb1c05c8
    15 anzsrc-for:11
    16 anzsrc-for:1102
    17 schema:author N1046afba6e0c424d907fe799688776b2
    18 schema:citation sg:pub.10.1007/s11897-008-0016-y
    19 schema:datePublished 2010-06-29
    20 schema:datePublishedReg 2010-06-29
    21 schema:description The natriuretic peptide (NP) family consists of structurally similar, although physiologically distinct, peptides that play an important role in cardiorenal homeostasis. CD-NP is a novel chimeric natriuretic peptide developed by the Mayo Clinic, in which the 15-amino acid COOH-terminus of dendroaspis NP is fused to C-type NP. CD-NP is a dual activator of NP receptors A and B, and therefore, possesses the strong antiproliferative and antifibrotic properties of C-type NP with the potent natriuretic, diuretic, and aldosterone-inhibiting properties of dendroaspis NP. CD-NP has favorable cardiorenal properties when compared to recombinant B-type NP (nesiritide), including preservation of glomerular filtration rate with minimal blood pressure-lowering effects. Thus, CD-NP has emerged as an appealing novel therapeutic strategy for heart failure. The endogenous NP system, the development rationale for CD-NP, as well as in vitro, animal, and human studies and future directions will be reviewed.
    22 schema:genre article
    23 schema:isAccessibleForFree false
    24 schema:isPartOf N331ef93832ab4bc7888d83b5da0f1ba1
    25 N4a1583f4550046ee972d04c8fa7c1c98
    26 sg:journal.1033049
    27 schema:keywords B-type NP
    28 C-type NP
    29 CdS NPs
    30 Mayo Clinic
    31 NP system
    32 NPs
    33 acid
    34 activator
    35 aldosterone-inhibiting properties
    36 animals
    37 antifibrotic properties
    38 blood pressure-lowering effect
    39 cardiorenal disease
    40 cardiorenal homeostasis
    41 clinic
    42 cyclase receptors
    43 dendroaspis NP
    44 development rationale
    45 direction
    46 disease
    47 dual activator
    48 effect
    49 failure
    50 family
    51 filtration rate
    52 future directions
    53 glomerular filtration rate
    54 guanylyl cyclase receptors
    55 heart failure
    56 homeostasis
    57 human studies
    58 important role
    59 natriuretic peptide
    60 natriuretic peptide family
    61 novel therapeutic strategies
    62 particulate guanylyl cyclase receptors
    63 peptide activator
    64 peptide family
    65 peptides
    66 preservation
    67 pressure-lowering effect
    68 properties
    69 rate
    70 rationale
    71 receptors
    72 role
    73 strategies
    74 study
    75 system
    76 terminus
    77 therapeutic strategies
    78 vitro
    79 schema:name CD-NP: An Innovative Designer Natriuretic Peptide Activator of Particulate Guanylyl Cyclase Receptors for Cardiorenal Disease
    80 schema:pagination 93-99
    81 schema:productId N2d8c5594eb5b4c6e87394a48daaa8e4c
    82 N4ee0f92b567c415e8e2024dd5007472b
    83 Na4fae49bcdc549799f094bb7c1494705
    84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022530445
    85 https://doi.org/10.1007/s11897-010-0016-6
    86 schema:sdDatePublished 2022-08-04T16:58
    87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    88 schema:sdPublisher Nbd58aa23dcdb4bd99b254c3b7f4faa35
    89 schema:url https://doi.org/10.1007/s11897-010-0016-6
    90 sgo:license sg:explorer/license/
    91 sgo:sdDataset articles
    92 rdf:type schema:ScholarlyArticle
    93 N04b93ba5f4a940a2bc4d4935ebdc5531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Intercellular Signaling Peptides and Proteins
    95 rdf:type schema:DefinedTerm
    96 N1046afba6e0c424d907fe799688776b2 rdf:first sg:person.01271304603.22
    97 rdf:rest N4a61518d88c945788ded34504ddb748e
    98 N1809a9ea0e8d4f0ca13647b3eba74e62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Diuretics
    100 rdf:type schema:DefinedTerm
    101 N18b1c8ea037d432ebaff05248b1d177f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Heart Failure
    103 rdf:type schema:DefinedTerm
    104 N1e98abf6fae047589b93797e9f0182f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Antihypertensive Agents
    106 rdf:type schema:DefinedTerm
    107 N2d8c5594eb5b4c6e87394a48daaa8e4c schema:name pubmed_id
    108 schema:value 20582736
    109 rdf:type schema:PropertyValue
    110 N2f4a3dafc4a1463ea7da5cab1d6bb98d rdf:first sg:person.01001266776.01
    111 rdf:rest rdf:nil
    112 N3008976dedaf45ddab09ef3179b01856 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Kidney
    114 rdf:type schema:DefinedTerm
    115 N331ef93832ab4bc7888d83b5da0f1ba1 schema:volumeNumber 7
    116 rdf:type schema:PublicationVolume
    117 N4410560da8c549b39fe86b63ec2f7952 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Drug Design
    119 rdf:type schema:DefinedTerm
    120 N4a1583f4550046ee972d04c8fa7c1c98 schema:issueNumber 3
    121 rdf:type schema:PublicationIssue
    122 N4a61518d88c945788ded34504ddb748e rdf:first sg:person.01032132346.11
    123 rdf:rest N2f4a3dafc4a1463ea7da5cab1d6bb98d
    124 N4ee0f92b567c415e8e2024dd5007472b schema:name doi
    125 schema:value 10.1007/s11897-010-0016-6
    126 rdf:type schema:PropertyValue
    127 N8d87309ff7c744dbad39c48c13d4ec41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Animals
    129 rdf:type schema:DefinedTerm
    130 Na090158251454779a213eb88dbba093c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Humans
    132 rdf:type schema:DefinedTerm
    133 Na4fae49bcdc549799f094bb7c1494705 schema:name dimensions_id
    134 schema:value pub.1022530445
    135 rdf:type schema:PropertyValue
    136 Naa7db89f97a84a8b8d575300fee9d69a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Peptides
    138 rdf:type schema:DefinedTerm
    139 Nbd58aa23dcdb4bd99b254c3b7f4faa35 schema:name Springer Nature - SN SciGraph project
    140 rdf:type schema:Organization
    141 Nc20349fbd7e6495aa83862fc5028b8d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Natriuretic Peptide, C-Type
    143 rdf:type schema:DefinedTerm
    144 Nc274d3b2db0649709d1df522091dcbc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Elapid Venoms
    146 rdf:type schema:DefinedTerm
    147 Nd11450996d274de58cf2b5162289737d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Glomerular Filtration Rate
    149 rdf:type schema:DefinedTerm
    150 Ne7550d0f08664ad9b9aa6333a12d03f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Chimera
    152 rdf:type schema:DefinedTerm
    153 Nfeb54198a8b9411c8a6cd57ebb1c05c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Receptors, Guanylate Cyclase-Coupled
    155 rdf:type schema:DefinedTerm
    156 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    157 schema:name Medical and Health Sciences
    158 rdf:type schema:DefinedTerm
    159 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    160 schema:name Cardiorespiratory Medicine and Haematology
    161 rdf:type schema:DefinedTerm
    162 sg:journal.1033049 schema:issn 1546-9530
    163 1546-9549
    164 schema:name Current Heart Failure Reports
    165 schema:publisher Springer Nature
    166 rdf:type schema:Periodical
    167 sg:person.01001266776.01 schema:affiliation grid-institutes:grid.66875.3a
    168 schema:familyName Burnett
    169 schema:givenName John C.
    170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01
    171 rdf:type schema:Person
    172 sg:person.01032132346.11 schema:affiliation grid-institutes:grid.66875.3a
    173 schema:familyName Sangaralingham
    174 schema:givenName S. Jeson
    175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032132346.11
    176 rdf:type schema:Person
    177 sg:person.01271304603.22 schema:affiliation grid-institutes:grid.66875.3a
    178 schema:familyName McKie
    179 schema:givenName Paul M.
    180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271304603.22
    181 rdf:type schema:Person
    182 sg:pub.10.1007/s11897-008-0016-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1038509334
    183 https://doi.org/10.1007/s11897-008-0016-y
    184 rdf:type schema:CreativeWork
    185 grid-institutes:grid.66875.3a schema:alternateName Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA
    186 schema:name Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA
    187 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...